Brief: Bivictrix Therapeutics PLC Extended Survival Rates Reported With Bvx001 In A Pre-Clinical Model Of Acute Myeloid Leukaemia
12/10/2023 07:07
Oct 12 (Reuters) - BiVictriX Therapeutics PLC BVX.L :
* EXTENDED SURVIVAL RATES REPORTED WITH BVX001 IN A
PRE-CLINICAL
MODEL OF ACUTE MYELOID LEUKAEMIA
Source text for Eikon: ID:nRSL8536Pa
Further company coverage: BVX.L
((Reuters.Briefs@thomsonreuters.com;;))